IVERIC bio Inc

NASDAQ:ISEE   3:59:52 PM EDT
21.08
+0.09 (+0.43%)
Products, Regulatory

Iveric Bio Announces Positive Topline Data From Zimura® Gather2 Phase 3 Clinical Trial In Geographic Atrophy

Published: 09/06/2022 11:20 GMT
IVERIC bio Inc (ISEE) - Iveric Bio Announces Positive Topline Data From Zimura® Gather2 Phase 3 Clinical Trial in Geographic Atrophy.
Iveric Bio Inc - Plan to Submit New Drug Application to FDA by End of Q1 2023.
Iveric Bio Inc - Gather2 Met Its Prespecified Primary Endpoint of Mean Rate of Growth (slope) in Ga Area at 12 Months.
Iveric Bio Inc - Statistically Significant Result With Favorable Safety Profile.